Data2Discovery’s patent-pending knowledge graph and advanced data science technologies are being used to find breakthrough insights in fields as diverse as drug discovery, disaster medicine and food science. Our advanced technology stack is able to integrate, organize and learn from large, complex, and heterogeneous data sources. With decades of experience and a powerful and unique software platform, we are meeting the world’s most important and difficult challenges. Here are some of the organizations Data2Discovery is helping achieve success.
![](https://images.squarespace-cdn.com/content/v1/58ed649137c58198053d92cb/95c58295-317a-44bc-aa4d-e4b9a1dcdfad/D2D+Companies.png)
In a significant application of its AI-based knowledge graph and data science technologies, Data2Discovery Inc has discovered a promising potential treatment for mycobacterium infections including Mycobacterium tuberculosis (MTB) and Mycobacterium Abscessus Complex (MABC). The treatment shows special promise for MABC, an increasingly impactful disease for which there is no current effective treatment.
Data2Discovery along with Indiana University Crisis Technologies Innovation Lab and two partner companies have been awarded a $2.3m contract from the US Army to create a Technology in Disaster Environments Learning Accelarator (TLA) that will use Data2Discovery’s proprietary graph technologies.
Data2Discovery is mentioned in this comprehensive list of startups using AI in drug discovery, curated by BenchSci, the world's most comprehensive AI-driven biomedical discovery platform, backed by Google’s AI fund.
In March 2017, Data2Discovery was awarded a $750,000 grant from the National Science Foundation (NSF) via the highly competitive Small Business Innovation Research (SBIR) Phase II program. The grant will support Data2Discovery's efforts to support translational and phenotypic research on vast interlinked datasets; which will include applications in Drug Repurposing, Toxicology and Safety, and Phenotypic Analysis.
The Open PHACTS Foundation is pleased to formally announce the recent collaboration with Data2Discovery to form a Strategic Partnership. The goals of the partnership will support and continue with the Open PHACTS vision of creating a sustainable, open, interoperable information infrastructure for applied life science research and development, while advancing science for the public benefit through shared knowledge and data in life science and biomedical research.
Among other key figures from pharma and biotech companies, Data2Discovery’s president, David Wild, will be giving a talk on: Boosting Machine Learning with Knowledge Graphs & Node Embeddings. David will be presenting three use cases showing how knowledge graphs that integrate multiple datasets can create new insights and potentially significantly improve efficiency and effectiveness of drug discovery.
Among other key figures from pharma and biotech companies, Data2Discovery’s president, David Wild, will be giving a talk on: Boosting Machine Learning with Knowledge Graphs & Node Embeddings. David will be presenting three use cases showing how knowledge graphs that integrate multiple datasets can create new insights and potentially significantly improve efficiency and effectiveness of drug discovery.
Data2Discovery is a sponsor of the AI Applications Summit: BioPharma in Boston October 25 & 26, 2018. President & Founder Dr David Wild will be speaking on Knowledge Graphs: A transformative new approach for drug discovery.